High levels of hepatitis B virus after the onset of disease lead to chronic infection in patients with acute hepatitis B

Clinical Infectious Diseases

Volumn 57, Issue 7, 2013, Pages 935-942

  Yotsuyanagi, Hiroshi ^a   Ito, Kiyoaki ^b,e   Yamada, Norie ^a,c,d   Takahashi, Hideaki ^c   Okuse, Chiaki ^c   Yasuda, Kiyomi ^d   Suzuki, Michihiro ^c   Moriya, Kyoji ^a   Mizokami, Masashi ^b   Miyakawa, Yuzo ^f   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Kiyokawa Hospital   (Japan)

^e AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f Miyakawa Memorial Research Foundation   (Japan)

Author keywords

Genotype; Hepatitis B virus; Hepatitis B virus antigen

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC DISEASE; CLEARANCE; CLINICAL FEATURE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PHYLOGENY; PRIORITY JOURNAL;

GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B VIRUS ANTIGEN;

ACUTE DISEASE; ADULT; CHI-SQUARE DISTRIBUTION; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; PHYLOGENY; PREVALENCE; RETROSPECTIVE STUDIES; VIRAL LOAD;

EID: 84884366172     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit348     Document Type: Article

References (26)

1. Kusakabe A, Tanaka Y, Mochida S, et al. Case-control study for the identification of virological factors associated with fulminant hepatitis B. Hepatol Res 2009; 39:648-56.
2. Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepat 1999; 6:299-304.
3. Tamada Y, Yatsuhashi H, Masaki N, et al. Hepatitis B virus strains of subgenotype A2 with an identical sequence spreading rapidly from the capital region to all over Japan in patients with acute hepatitis B. Gut 2012; 61:765-73.
4. Kobayashi M, Arase Y, Ikeda K, et al. Clinical features of hepatitis B virus genotype A in Japanese patients. J Gastroenterol 2003; 38:656-62.
5. Yotsuyanagi H, Okuse C, Yasuda K, et al. Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan. J Med Virol 2005; 77:39-46.
6. Zhang HW, Yin JH, Li YT, et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 2008; 57: 1713-20.
7. Reijnders JG, Rijckborst V, Sonneveld MJ, et al. Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir. J Hepatol 2011; 54:449-54.
8. Sonneveld MJ, Rijckborst V, Boucher CA, Hansen BE, Janssen HL. Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline. Hepatology 2010; 52:1251-7.
9. Wursthorn K, Jung M, Riva A, et al. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients. Hepatology 2010; 52:1611-20.
10. Brunetto MR, Oliveri F, Colombatto P, et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 2010; 139:483-90.
11. Jaroszewicz J, Calle Serrano B, Wursthorn K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV) infection: a European perspective. J Hepatol 2010; 52:514-22.
12. Kato H, Orito E, Sugauchi F, et al. Frequent coinfection with hepatitis B virus strains of distinct genotypes detected by hybridization with typespecific probes immobilized on a solid-phase support. J Virol Methods 2003; 110:29-35.
13. Yano K, Tamada Y, Yatsuhashi H, et al. Dynamic epidemiology of acute viral hepatitis in Japan. Intervirology 2010; 53:70-5.
14. Matsuura K, Tanaka Y, Hige S, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol 2009; 47:1476-83.
15. Gojobori T, Ishii K, Nei M. Estimation of average number of nucleotide substitutions when the rate of substitution varies with nucleotide. J Mol Evol 1982; 18:414-23.
16. Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 1987; 4:406-25.
17. Felsenstein J. Confidence limits on phylogenesis, an approach using the bootstrap. Evolution 1985; 39:783-91.
18. Ogawa M, Hasegawa K, Naritomi T, Torii N, Hayashi N. Clinical features and viral sequences of various genotypes of hepatitis B virus compared among patients with acute hepatitis B. Hepatol Res 2002; 23: 167-77.
19. Sugiyama M, Tanaka Y, Kurbanov F, et al. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes. Gastroenterology 2009; 136:652-62. e3.
20. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med 2001; 135:759-68.
21. Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15(suppl):E25-30.
22. Kamatani Y,Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41:591-5.
23. Kumar M, Satapathy S, Monga R, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007; 45:97-101.
24. Tassopoulos NC, Koutelou MG, Polychronaki H, Paraloglou-Ioannides MHadziyannis SJ. Recombinant interferon-alpha therapy for acute hepatitis B: a randomized, double-blind, placebo-controlled trial. J Viral Hepat 1997; 4:387-94.
25. Aldershvile J, Frösner GG, Nielsen JO, et al. Hepatitis B e antigen and antibody measured by radioimmunoassay in acute hepatitis B surface antigen-positive hepatitis. J Infect Dis 1980; 141:293-8.
26. Aldershvile J, Nielsen JO. HBeAg, anti-HBe and anti-HBc IgM in patients with hepatitis B. J Virol Methods 1980; 2:97-105.